by Keith Lind Posted on 11/15/2018
When my parents got into their 80s, sometimes I
thought they were arguing because they were shouting. Then I realized they were
just having trouble hearing each other. Unfortunately, this went on for some
time because they did not have hearing aids. They said hearing aids were too
expensive.
Expense may soon become less of an issue for
would-be purchasers. Recently, the Food and Drug Administration
(FDA) approved the first hearing aid for sale over-the-counter (OTC).
Allowing OTC sales of hearing aids, something that AARP has supported, promises
to bring down the cost of these devices and make them much more accessible to
millions of older Americans with hearing loss.
This action has been long awaited.
Prior to the FDA’s action, cost has been a major
barrier to getting hearing aids. The average price for a hearing aid is more
than $2,300 with some costing over $5,000—and most people need two of them.
Currently, most people have to pay the full cost of hearing aids out-of-pocket
because these costs are not covered by insurance. While some state Medicaid
programs cover hearing aids, Medicare expressly excludes coverage for them.
Thus, primarily as a result of their cost,
hearing aid use has been relatively low: only 15 percent to 30 percent of
people who need them have them.
The low uptake of hearing aids poses problems
for many reasons. Hearing loss is a substantial problem, affecting more than 30
million Americans, including nearly 80 percent of people over 80 years old.
Left untreated, hearing loss can negatively affect older persons’ quality of
life by preventing them from engaging with others, leading to social isolation
and limiting ability to work. Hearing loss also has been
associated with depression, dementia, cognitive decline, and poorer physical
functioning. Studies have also shown that even mild hearing loss
is associated with a threefold increase in falls.
In 2016, the President’s Council of Advisors
on Science and Technology and the National Academy of Medicine (formerly
known as the Institute of Medicine) recommended policy changes that would help
lower the cost and promote greater use of hearing aids. The experts recommended
that the FDA establish a new classification for basic hearing aids and allow
these devices to be sold OTC at drug stores for the treatment of mild to
moderate hearing loss—similar to what is allowed for reading glasses. In 2017, Congress passed
legislation that directed the FDA to do exactly that. The FDA is also expected to take
other steps to facilitate access to more complex hearing aids.
As basic hearing aids come on the market as OTC
devices, their cost is expected to decline to a few hundred dollars. Competition for more complex
devices could also intensify and prices decline as regulatory restrictions are
relaxed.
Lower hearing aid costs will be good news for
consumers, especially seniors with hearing loss. Increased competition and
declining costs may also give policy makers greater leeway to consider adopting
Medicare coverage for these devices and related support services, which would
be of great benefit to current and future beneficiaries.
Keith Lind is a Senior Strategic Policy Adviser for the AARP
Public Policy Institute, where he covers issues related to Medicare and medical
devices.
https://blog.aarp.org/2018/11/15/hearing-aid-prices-are-coming-down-is-now-the-time-to-consider-getting-one/?autologin=true&CMP=EMC-ADV-NLC-ADV-OTHER-null-null-112918
No comments:
Post a Comment